Trademark: COUMADIN (WARFARIN SODIUM TABLETS, USP)
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
COUMADIN (WARFARIN SODIUM TABLETS, USP)
Click here to search for trademarks similar to COUMADIN (WARFARIN SODIUM TABLETS, USP)
Proof of use for COUMADIN (WARFARIN SODIUM TABLETS, USP)
We do not have any records of a proof of use for COUMADIN (WARFARIN SODIUM TABLETS, USP) at this moment.
Click here to add a proof of use for COUMADIN (WARFARIN SODIUM TABLETS, USP)
Possible trademark infringements of COUMADIN (WARFARIN SODIUM TABLETS, USP)
Basic Information about COUMADIN (WARFARIN SODIUM TABLETS, USP)
- Serial Number
- 87226817
- Filing Date
- 04 Nov 2016
- Registration Number
- 5222641
- Registration Date
- 13 Jun 2017
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of COUMADIN (WARFARIN SODIUM TABLETS, USP) on the blockchain with WikiTrademarks.io.
- First use of COUMADIN (WARFARIN SODIUM TABLETS, USP) anywhere
- COUMADIN (WARFARIN SODIUM TABLETS, USP) was first used on 12 Apr 2002 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns COUMADIN (WARFARIN SODIUM TABLETS, USP)?
1. Bristol-Myers Squibb Pharma Company Princeton NJ
2. Bristol-Myers Squibb Pharma Company Princeton NJ
3. Bristol-Myers Squibb Pharma Company Princeton NJ
Correspondent
- MARILYN F. KELLY
- BRISTOL-MYERS SQUIBB COMPANY
- P.O. BOX 4000
- TRADEMARKS DEPT., MAILSTOP D33-05
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io